More articles from Volume 48, Issue 3, 2019
Non-melanoma malignat skin tumors: One year analysis
Assessment of the risk status of diseases associated with overweight in students of the University of Pristina - Kosovska Mitrovica
Testing the correlation between occupational stress and occupational burnout among nurses working in public health institutions
Autoimmune diseases with thousand faces
Hypersensitivity pneumonitis with frequent hemoptysis
Autoimmune diseases with thousand faces
,
Hajnalka Požar
Čaba Požar
Abstract
References
1.
Simsek H, Zorlu E, Bakal O, Akarsu S, Güney S. Continuous intrathecal baclofen delivery in severely disabling spasticity. Vojnosanitetski pregled. 2018;75(11):1076–82.
2.
Anaya JM, Corena R, Castiblanco J, Rojas-Villarraga A, Shoenfeld Y. The kaleidoscope of autoimmunity: multiple autoimmune syndromes and familial autoimmunity. Expert Review of Clinical Immunology. 2007;3(4):623–35.
3.
Gao S, Luo H, Zhang H, Zuo X, Wang L, Zhu H. Using multi-omics methods to understand dermatomyositis/polymyositis. Autoimmunity Reviews. 2017;16(10):1044–8.
4.
Findlay AR, Goyal NA, Mozaffar T. An overview of polymyositis and dermatomyositis. Muscle & Nerve. 2015;51(5):638–56.
5.
Anić B, Cerovec M. Polimiozitis / Dermatomiozitis -klinička slika i terapija. 2012;59(2):44–50.
6.
Martinović-Kaliterna D, Perković D, Marasović-Krstulović D. Polimiozitis, dermatomiozitis: sindromi preklapanja s autoimunim i malignim bolestima. 2012;59(2):51–2.
7.
MSD priručnik dijagnostike i terapije. Sjögrenov sindrom. 2014.
8.
Barišić N, Ivanović V, Lehman I, Grđan P. Paediatria Croatica. Paediatria Croatica. 2013;57(4):338–43.
9.
MSD priručnik dijagnostike i terapije. Sistemski lupus eritematodes. 2014.
10.
Veinovic G, Stojic-Vukanic Z, Antic-Stankovic J. Lyme borreliosis: Epidemiology, clinical manifestations and treatment. Arhiv za farmaciju. 2015;65(2):129–46.
11.
Villines Z. How does Dawson’s finger relate to multiple sclerosis?
12.
Peric P, Antic B, Dincic E, Obradovic D, Arsic S. Treatment of severe spacticity in multiple sclerosis by continuous intrathecal baclofen. Vojnosanitetski pregled. 2006;63(2):187–91.
13.
Jovičić J, Volaš L, Brkić T, Terzić B, Garić A, Gvozdić B, et al. Opstacles in neuropathic pain treatment in the developing country: Neuropathic pain treatment. Serbian Journal of Anesthesia and Intensive Therapy. 2018;40(3–4):103–7.
14.
Stepanovic-Petrovic R, Micov A. Novel approaches in the treatment of multiple sclerosis. Arhiv za farmaciju. 2015;65(4):223–36.
15.
Republička stručna komisija za izradu i implementaciju vodiča dobre kliničke prakse. Nacionalni vodič dobre kliničke prakse za dijagnostikovanje i lečenje multiple skleroze. 2013;19(13).
16.
Kostić. Analiza kliničkog toka i progresije multiple skleroze: rezultati studije petogodišnjeg praćenja bolesnika u Srbiji. In 2013.
17.
Thompson AJ, Toosy AT, Ciccarelli O. Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions. The Lancet Neurology. 2010;9(12):1182–99.
18.
Stankov S, Stepančev B. Vitamin D role in multiple sclerosis etiology and therapy. Medicinski casopis. 2018;52(1):15–21.
19.
Đorđević G, Stamenović J. DEMYELINATION OF THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM: A CASE REPORT. Acta medica Medianae. 2017;56(1):39–43.
20.
Kamińska J, Koper OM, Piechal K, Kemona H. Multiple sclerosis - etiology and diagnostic potential. Postępy Higieny i Medycyny Doświadczalnej. 2017;71(1):0–0.
21.
Suknjaja V. Povezanost vremena nastanka multiple skleroze sa karakteristikama kliničke slike, toka bolesti, nalazima nuklearne magnetne rezonance i likvora. In 2016.
22.
Ivanović J, Pekmezović T, Drulović J. Interferon beta: Medication which started the revolution in the treatment of multiple sclerosis. Medicinski podmladak. 2019;70(1):53–7.
23.
Palibrk I, Veličković J. Anesthesia in patients with neurological diseases: Coma (neurological disorders and anesthesia). Serbian Journal of Anesthesia and Intensive Therapy. 2018;40(1–2):45–53.
24.
Todorovic-Djilas L, Icin T, Novakovic-Paro J, Bajkin I. Autoimmune thyroid disease and other non-endocrine autoimmune diseases. Medical review. 2011;64(3–4):183–7.
Citation
Copyright
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Article metrics
Google scholar:
See link
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
